{"transactions":[{"id":2259556,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-23T20:17:43.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":22058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest in equal annual installments over the three-year period following the grant date of May 19, 2022."}],"balance_after":22058,"derivative":{"exercise_price":3.3,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":22058},"source":{"system":"sec-edgar","filing":"0001209191-22-031503","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1509669/000120919122031503/doc4.xml","form_type":"4"}},{"id":2259555,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T20:17:43.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":63974,"ownership":{"direct":false,"nature":"By Philip S. Low Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 19, 2022, the Issuer completed acquisition (the \"Merger\") of Novosteo Inc. (\"Novosteo\"), pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of May 9, 2022, (the \"Merger Agreement\"), by and among the Issuer, Quince Merger Sub I, Inc., a wholly owned subsidiary of the Issuer, Quince Merger Sub II, LLC, a wholly owned subsidiary of the Issuer, Novosteo, and Fortis Advisors LLC, solely in its capacity as the securityholders' representative. Pursuant to the terms of the Merger Agreement, at the closing of the Merger, the shares held by the Reporting Person in Novosteo were automatically cancelled and converted into the right to receive shares of common stock of the Issuer."}],"balance_after":63974,"source":{"system":"sec-edgar","filing":"0001209191-22-031503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1509669/000120919122031503/doc4.xml","form_type":"4"}},{"id":2259554,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-23T20:17:43.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":455309,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 19, 2022, the Issuer completed acquisition (the \"Merger\") of Novosteo Inc. (\"Novosteo\"), pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of May 9, 2022, (the \"Merger Agreement\"), by and among the Issuer, Quince Merger Sub I, Inc., a wholly owned subsidiary of the Issuer, Quince Merger Sub II, LLC, a wholly owned subsidiary of the Issuer, Novosteo, and Fortis Advisors LLC, solely in its capacity as the securityholders' representative. Pursuant to the terms of the Merger Agreement, at the closing of the Merger, the shares held by the Reporting Person in Novosteo were automatically cancelled and converted into the right to receive shares of common stock of the Issuer."}],"balance_after":455309,"source":{"system":"sec-edgar","filing":"0001209191-22-031503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1509669/000120919122031503/doc4.xml","form_type":"4"}},{"id":3720871,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":45000,"price":20.99,"value":944550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This Company stock option was scheduled to vest 1/4 annually over a period of 4 years beginning on February 8, 2019. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This Company stock option was scheduled to vest 1/4 annually over a period of 4 years beginning on February 8, 2019. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.01,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720870,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":35000,"price":21.84,"value":764400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This Company stock option was scheduled to vest 1/4 annually over a period of 4 years beginning on February 2, 2018. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This Company stock option was scheduled to vest 1/4 annually over a period of 4 years beginning on February 2, 2018. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":2.16,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720869,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":52498,"price":20.82,"value":1093008.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This Company stock option was scheduled to vest 1/4 annually over a period of 4 years beginning on February 4, 2017. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This Company stock option was scheduled to vest 1/4 annually over a period of 4 years beginning on February 4, 2017. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.18,"expiration_date":"2026-02-04","underlying":"Common Stock","underlying_shares":52498},"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720868,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":52498,"price":18.9,"value":992212.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":5.1,"expiration_date":"2025-02-04","underlying":"Common Stock","underlying_shares":52498},"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720867,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":36000,"price":12.89,"value":464040.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":11.11,"expiration_date":"2024-02-06","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720866,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":56918,"price":14.14,"value":804820.52,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":9.86,"expiration_date":"2023-02-19","underlying":"Common Stock","underlying_shares":56918},"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720865,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":59996,"price":20.45,"value":1226918.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.55,"expiration_date":"2022-02-28","underlying":"Common Stock","underlying_shares":59996},"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720864,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":17950,"price":12.2,"value":218990.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":11.8,"expiration_date":"2021-05-26","underlying":"Common Stock","underlying_shares":17950},"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720863,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":8560,"price":14.95,"value":127972.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":9.05,"expiration_date":"2021-04-14","underlying":"Common Stock","underlying_shares":8560},"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720862,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":13570,"price":20.18,"value":273842.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This Company stock option was fully vested immediately prior to the Effective Time. Pursuant to the Merger Agreement, at the Effective Time, each Company stock option that was outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to the excess of $24.00 over the exercise price with respect to such stock option, multiplied by the number of shares of Company common stock subject to such stock option, less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":3.82,"expiration_date":"2020-02-11","underlying":"Common Stock","underlying_shares":13570},"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720861,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Common Stock","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":22500,"price":24,"value":540000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This RSU award provided for vesting and settlement 1/4 annually over a period of 4 years beginning on February 8, 2019 in the form of one share of Company common stock for each RSU. Pursuant to the Merger Agreement, at the Effective Time, each RSU outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to $24.00, multiplied by the number of shares of Company common stock subject to such RSU, less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720860,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Common Stock","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":24,"value":480000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This RSU award, which originally consisted of 40,000 RSUs and of which 20,000 RSUs had vested and been settled as of immediately prior to the Effective Time, provided for vesting and settlement 1/2 annually over a period of 2 years beginning on October 4, 2018 in the form of one share of Company common stock for each RSU. Pursuant to the Merger Agreement, at the Effective Time, each RSU outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to $24.00, multiplied by the number of shares of Company common stock subject to such RSU, less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720859,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Common Stock","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":13125,"price":24,"value":315000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This RSU award, which originally consisted of 17,500 RSUs and of which 4,375 RSUs had vested and been settled as of immediately prior to the Effective Time, provided for vesting and settlement 1/4 annually over a period of 4 years beginning on February 2, 2018 in the form of one share of Company common stock for each RSU. Pursuant to the Merger Agreement, at the Effective Time, each RSU outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to $24.00, multiplied by the number of shares of Company common stock subject to such RSU, less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720858,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Common Stock","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":4375,"price":24,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This restricted stock unit (\"RSU\") award, which originally consisted of 8,750 RSUs and of which 4,375 RSUs had vested and been settled as of immediately prior to the Effective Time, provided for vesting and settlement 1/4 annually over a period of 4 years beginning on February 4, 2017 in the form of one share of Company common stock for each RSU. Pursuant to the Merger Agreement, at the Effective Time, each RSU outstanding immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash, without interest, equal to $24.00, multiplied by the number of shares of Company common stock subject to such RSU, less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720857,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Common Stock","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":132473,"price":24,"value":3179352.0,"ownership":{"direct":false,"nature":"By Spouse Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 17, 2018 (the \"Merger Agreement\"), by and among Endocyte, Inc. (the \"Company\"), Novartis AG (\"Novartis\") and Edinburgh Merger Corporation, a wholly owned subsidiary of Novartis (\"Merger Sub\"), at the effective time (the \"Effective Time\") of the merger of Merger Sub with and into the Company, which Effective Time occurred on December 21, 2018, each share of Company common stock was converted into the right to receive an amount in cash equal to $24.00, without interest and less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3720856,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief  Science Officer"}}],"security":"Common Stock","published_at":"2018-12-21T12:47:20.000Z","date":"2018-12-21","kind":"disposition_to_issuer","acquired":false,"shares":349944,"price":24,"value":8398656.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 17, 2018 (the \"Merger Agreement\"), by and among Endocyte, Inc. (the \"Company\"), Novartis AG (\"Novartis\") and Edinburgh Merger Corporation, a wholly owned subsidiary of Novartis (\"Merger Sub\"), at the effective time (the \"Effective Time\") of the merger of Merger Sub with and into the Company, which Effective Time occurred on December 21, 2018, each share of Company common stock was converted into the right to receive an amount in cash equal to $24.00, without interest and less any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-18-074339","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000110465918074339/a4.xml","form_type":"4"}},{"id":3724446,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares subject to this option vest 1/4 annually over a period of four years beginning February 4, 2017."}],"balance_after":52498,"derivative":{"exercise_price":3.18,"expiration_date":"2026-02-04","underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724445,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and immediately exercisable."}],"balance_after":52498,"derivative":{"exercise_price":5.1,"expiration_date":"2025-02-04","underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724444,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and immediately exercisable."}],"balance_after":36000,"derivative":{"exercise_price":11.11,"expiration_date":"2024-02-06","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724443,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":13082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and immediately exercisable."}],"balance_after":56918,"derivative":{"exercise_price":9.86,"expiration_date":"2023-02-19","underlying":"Common Stock","underlying_shares":13082},"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724442,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":20004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and immediately exercisable."}],"balance_after":59996,"derivative":{"exercise_price":3.55,"expiration_date":"2022-02-28","underlying":"Common Stock","underlying_shares":20004},"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724441,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":2050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and immediately exercisable."}],"balance_after":17950,"derivative":{"exercise_price":11.8,"expiration_date":"2021-05-26","underlying":"Common Stock","underlying_shares":2050},"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724440,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":21440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and immediately exercisable."}],"balance_after":8560,"derivative":{"exercise_price":9.05,"expiration_date":"2021-04-14","underlying":"Common Stock","underlying_shares":21440},"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724439,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":51875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and immediately exercisable."}],"balance_after":13570,"derivative":{"exercise_price":3.82,"expiration_date":"2020-02-11","underlying":"Common Stock","underlying_shares":51875},"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724438,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":false,"shares":22759,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.54,"expiration_date":"2019-03-05","underlying":"Common Stock","underlying_shares":22759},"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724437,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":2,"price":3.18,"value":6.36,"ownership":{"direct":true},"balance_after":409944,"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724436,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":2,"price":5.1,"value":10.2,"ownership":{"direct":true},"balance_after":409942,"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724435,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":9000,"price":11.11,"value":99990.0,"ownership":{"direct":true},"balance_after":409940,"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724434,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":13082,"price":9.86,"value":128988.52,"ownership":{"direct":true},"balance_after":400940,"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724433,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":20004,"price":3.55,"value":71014.2,"ownership":{"direct":true},"balance_after":387858,"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724432,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":2050,"price":11.8,"value":24190.0,"ownership":{"direct":true},"balance_after":367854,"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724431,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":21440,"price":9.05,"value":194032.0,"ownership":{"direct":true},"balance_after":365804,"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724430,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":51875,"price":3.82,"value":198162.5,"ownership":{"direct":true},"balance_after":344364,"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724429,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-17","kind":"exercise","acquired":true,"shares":22759,"price":2.54,"value":57807.86,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 526 shares acquired under the 2010 Endocyte, Inc. Employee Stock Purchase Plan on December 14, 2018."}],"balance_after":292489,"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724428,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-12","kind":"gift","acquired":false,"shares":52346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a gift of 52,346 shares to a non-profit organization."}],"balance_after":269204,"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3724427,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-12-19T16:13:21.000Z","date":"2018-12-12","kind":"gift","acquired":false,"shares":52512,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents gifts of 52,512 shares by Spouse Trust to non-profit organizations."}],"balance_after":132473,"source":{"system":"sec-edgar","filing":"0001179110-18-014132","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018014132/edgar.xml","form_type":"4"}},{"id":3789734,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-10-16T16:18:15.000Z","date":"2018-10-05","kind":"sale","acquired":false,"shares":5928,"price":15.5597,"value":92237.9016,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of 5,928 shares in multiple transactions ranging in price from $15.1400 to $15.9200, resulting in a weighted-average price of $15.5597.  The 5,928 shares were sold to cover taxes, commissions and fees associated with the October 4, 2018 settlement of 20,000 restricted stock units in the form of Company common stock on a one-for-one basis.  The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,733 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2018 that were inadvertently omitted from the amount of securities beneficially owned by the reporting person as reported on the Form 4 filed by the reporting person on October 9, 2018."}],"balance_after":321550,"source":{"system":"sec-edgar","filing":"0001179110-18-012206","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018012206/edgar.xml","form_type":"4/A","original_submission_date":"2018-10-09"}},{"id":3789733,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-10-16T16:18:15.000Z","date":"2018-09-07","kind":"gift","acquired":false,"shares":294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,733 shares acquired under the Endocyte, Inc. 2010 Employee Stock Purchase Plan on June 15, 2018 that were inadvertently omitted from the amount of securities beneficially owned by the reporting person as reported on the Form 4 filed by the reporting person on October 9, 2018."}],"balance_after":327478,"source":{"system":"sec-edgar","filing":"0001179110-18-012206","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018012206/edgar.xml","form_type":"4/A","original_submission_date":"2018-10-09"}},{"id":3794173,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-10-09T14:14:22.000Z","date":"2018-10-05","kind":"sale","acquired":false,"shares":5928,"price":15.5597,"value":92237.9016,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of 5,928 shares in multiple transactions ranging in price from $15.1400 to $15.9200, resulting in a weighted-average price of $15.5597.  The 5,928 shares were sold to cover taxes, commissions and fees associated with the October 4, 2018 settlement of 20,000 restricted stock units in the form of Company common stock on a one-for-one basis.  The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934."}],"balance_after":319817,"source":{"system":"sec-edgar","filing":"0001179110-18-012085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018012085/edgar.xml","form_type":"4"}},{"id":3794172,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-10-09T14:14:22.000Z","date":"2018-09-07","kind":"gift","acquired":false,"shares":294,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":325745,"source":{"system":"sec-edgar","filing":"0001179110-18-012085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018012085/edgar.xml","form_type":"4"}},{"id":4070203,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-02-08T16:45:20.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock subject to the option will vest 1/4 annually over a 4 year period beginning 2/8/19."}],"balance_after":45000,"derivative":{"exercise_price":3.01,"expiration_date":"2028-02-08","underlying":"Common stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001179110-18-001812","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018001812/edgar.xml","form_type":"4"}},{"id":4070202,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-02-08T16:45:20.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that will vest 1/4 annually over a 4 year period beginning 2/8/19, in the form of one share of common stock for each restricted stock unit."}],"balance_after":326039,"source":{"system":"sec-edgar","filing":"0001179110-18-001812","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018001812/edgar.xml","form_type":"4"}},{"id":4116938,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-02T15:39:21.000Z","date":"2017-12-28","kind":"exercise","acquired":false,"shares":65445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":3.06,"expiration_date":"2018-02-12","underlying":"Common Stock","underlying_shares":65445},"source":{"system":"sec-edgar","filing":"0001179110-18-000069","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018000069/edgar.xml","form_type":"4"}},{"id":4116937,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-01-02T15:39:21.000Z","date":"2017-12-22","kind":"gift","acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By spouse trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a gift of 8,333 shares by Spouse Trust to a non-profit organization."}],"balance_after":184985,"source":{"system":"sec-edgar","filing":"0001179110-18-000069","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018000069/edgar.xml","form_type":"4"}},{"id":4116936,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-01-02T15:39:21.000Z","date":"2017-12-28","kind":"sale","acquired":false,"shares":50511,"price":4.4114,"value":222824.2254,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of 50,511 shares in multiple transactions, ranging in price from $4.2700 to $4.5100 per share, resulting in a weighted average sale price per share of $4.4114. These shares were sold to cover the option exercise cost, taxes and fees in connection with the reporting person's exercise of stock options on December 28, 2017 as reported herein. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":303539,"source":{"system":"sec-edgar","filing":"0001179110-18-000069","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018000069/edgar.xml","form_type":"4"}},{"id":4116935,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2018-01-02T15:39:21.000Z","date":"2017-12-28","kind":"exercise","acquired":true,"shares":65445,"price":3.06,"value":200261.7,"ownership":{"direct":true},"balance_after":354050,"source":{"system":"sec-edgar","filing":"0001179110-18-000069","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911018000069/edgar.xml","form_type":"4"}},{"id":4163464,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2017-11-14T15:26:26.000Z","date":"2017-11-13","kind":"purchase","acquired":true,"shares":5600,"price":4.84,"value":27104.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the purchase of 5,600 shares in multiple transactions, ranging in price from $4.825 to $4.850 per share, resulting in a weighted average purchase price per share of $4.840. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":288605,"source":{"system":"sec-edgar","filing":"0001179110-17-014106","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911017014106/edgar.xml","form_type":"4"}},{"id":4163463,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2017-11-14T15:26:26.000Z","date":"2017-11-10","kind":"gift","acquired":false,"shares":5600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a gift of 5,600 shares to a non-profit organization, and, subsequently, there was a purchase of 5,600 shares in the open market, as reported on the next line of this Form 4."}],"balance_after":283005,"source":{"system":"sec-edgar","filing":"0001179110-17-014106","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911017014106/edgar.xml","form_type":"4"}},{"id":4190151,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2017-10-06T17:09:16.000Z","date":"2017-10-04","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that will vest and be paid 1/2 annually over a period of 2 years beginning on October 4, 2018, in the form of share of common stock for each restricted stock unit."}],"balance_after":288605,"source":{"system":"sec-edgar","filing":"0001179110-17-013185","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911017013185/edgar.xml","form_type":"4"}},{"id":4463844,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2017-02-07T19:25:23.000Z","date":"2017-02-06","kind":"tax_withholding","acquired":false,"shares":694,"price":2.18,"value":1512.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations associated with the settlement of 1,875 restricted stock units in the form of Company common stock on a one-for-one basis on February 6, 2017."}],"balance_after":248605,"source":{"system":"sec-edgar","filing":"0001179110-17-001932","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911017001932/edgar.xml","form_type":"4"}},{"id":4463843,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2017-02-07T19:25:23.000Z","date":"2017-02-04","kind":"tax_withholding","acquired":false,"shares":1888,"price":2.18,"value":4115.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations associated with the settlement of 2,916 and 2,187 restricted stock units in the form of Company common stock on a one-for-one basis on February 4, 2017."}],"balance_after":249299,"source":{"system":"sec-edgar","filing":"0001179110-17-001932","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911017001932/edgar.xml","form_type":"4"}},{"id":4468187,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option(right to buy)","published_at":"2017-02-03T15:50:32.000Z","date":"2017-02-02","kind":"grant","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest 1/4 annually over a period of 4 years beginning on February 2, 2018."}],"balance_after":35000,"derivative":{"exercise_price":2.16,"expiration_date":"2027-02-02","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001179110-17-001601","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911017001601/edgar.xml","form_type":"4"}},{"id":4468186,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2017-02-03T15:50:32.000Z","date":"2017-02-02","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that will vest and be paid 1/4 annually over a period of 4 years beginning on February 2, 2018, in the form of one share of common stock for each restricted stock unit."}],"balance_after":251187,"source":{"system":"sec-edgar","filing":"0001179110-17-001601","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911017001601/edgar.xml","form_type":"4"}},{"id":4552663,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Stock Option(right to buy)","published_at":"2016-11-16T16:01:38.000Z","date":"2016-11-15","kind":"exercise","acquired":false,"shares":15706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.1,"expiration_date":"2017-02-01","underlying":"Common Stock","underlying_shares":15706},"source":{"system":"sec-edgar","filing":"0001179110-16-031680","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911016031680/edgar.xml","form_type":"4"}},{"id":4552662,"issuer":{"id":161591,"kind":"organization","name":"ENDOCYTE INC","symbol":"ECYT"},"owners":[{"id":127018,"kind":"person","name":"Low Philip S","position":1,"cik":"0001509669","reported_name":"Low Philip S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Science Officer"}}],"security":"Common Stock","published_at":"2016-11-16T16:01:38.000Z","date":"2016-11-15","kind":"exercise","acquired":true,"shares":15706,"price":2.1,"value":32982.6,"ownership":{"direct":true},"balance_after":233687,"source":{"system":"sec-edgar","filing":"0001179110-16-031680","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235007/000117911016031680/edgar.xml","form_type":"4"}}]}